Healthcare SEO consulting

Health content is held to a higher bar, and what you may say about a treatment changes at every border. YMYL scrutiny, medical review, regulated claims and per-market search — four things that make healthcare SEO a different job from SEO in any other category.

9 markets21 properties monitored weekly37 to 3,100 URLs

Two jobs under one name

Search for “healthcare SEO” and most of what you find is written for clinics and practices: map listings, reviews, “doctor near me”. That is a local-search job, and a single clinic is a smaller engagement. This page is about the other job: a brand or organisation that sells, publishes or provides care across several countries, where the questions are who holds the results page for the queries that matter, and what you are allowed to put on it.

What is different about health

1. You rank against institutions

In my check of eight treatment queries in the United States, Germany and Spain, hospitals, universities, medical societies, patient groups, public bodies and insurers held 72% of the US top-10 organic slots, 62% in Germany and 53% in Spain. Manufacturer-run sites held 2%, 13% and 7%. The opening is by market and by layer of the search, not by keyword. The full breakdown is here.

2. What you may publish is set by law, market by market

In the EU, advertising prescription-only medicines to the public is prohibited, while statements about health or diseases that make no reference, even indirect, to medicinal products fall outside the definition of advertising. The United States regulates instead of prohibiting. The visible result: manufacturers hold 13% of German results through disease-information sites and 2% of American ones. SEO has to follow the regulatory status of each product in each market, and your regulatory team decides what is compliant. The law and the data are in this note.

3. Medical review is a scheduling constraint

A health page needs a named author, a named reviewer and a review date, and the review queue sets how fast you can publish. A content calendar that ignores it ships late or ships unreviewed. Plan around the queue, and make the credit machine-readable so engines can see it. More on claims, review and E-E-A-T.

4. AI answers cite institutions, and access can fail without anyone noticing

In the United States, Mayo Clinic or Cleveland Clinic was a source in every AI Overview I checked. In a robots.txt check of 94 healthcare sites, none of the 43 readable pharma and medtech files blocked an AI crawler, but Pfizer, Bayer and Teva refused my request outright: a firewall can sit in front of a permissive file. Brands that stay reachable have an opening that many health publishers have closed.

How I work on it

  1. Map products against markets

    For each product or service in each market: its regulatory status, who the audience is (patient, professional or both) and what can be published, agreed with your regulatory team before any keyword work.

  2. Measure the results page

    For your priority conditions or categories in each market, who holds the top ten and which sources the AI answers cite. The same method as my published research, run on your queries.

  3. Decide the asset per market

    Which page types carry search where: product pages, disease information, professional content. One URL per market, and hreflang only between pages that are genuinely equivalent.

  4. Make credibility legible

    Authors, medical reviewers and review dates, with the markup that lets an engine read them, planned around the review calendar rather than against it.

  5. Check access

    robots.txt, the firewall and gating: what crawlers and AI engines can actually fetch, and what sits behind a login by design.

  6. Set up measurement

    Per-market segmentation in Search Console and analytics, plus AI-visibility tracking, so you can tell in month three whether it is working rather than in month twelve.

Where this comes from

In my day job I look after 21 web properties across nine countries — consumer health portals, professional platforms and brand sites, from 37 URLs to 3,100 — with technical audits running weekly on all of them. Not theory: nine markets, in healthcare, where YMYL scrutiny, medical review workflows and regulated claims make every content decision slower and every technical mistake more expensive.

Who this is for

  • Health brands expanding across countries: clinic groups, telehealth, diagnostics, supplement and skincare brands.
  • Medical device and medtech companies selling into several markets.
  • Health publishers and portals publishing in more than one language.
  • Pharmaceutical companies whose markets and regulatory status shape what can rank, outside the exclusion below.
  • Agencies that serve these clients and need the international health work done behind their own brand.
Who I do not work with

I hold a full-time role at ALK-Abelló. To keep that relationship clean I do not take clients active in allergy immunotherapy, competitors of ALK-Abelló, or agencies and vendors serving ALK-Abelló. It is written into my terms, and consulting happens outside working hours with client data and tooling kept entirely separate.

What you walk away with

  • A per-market map of who holds the results page for your priority queries, and where you can realistically compete.
  • A per-market asset plan: which page types carry search where, and which hreflang pairs should not exist.
  • A credibility spec: authors, reviewers, review dates and structured data, fitted to your review calendar.
  • An access check: robots.txt, firewall and gating, crawler by crawler.
  • An AI-visibility baseline: patient and professional questions per market, run against six AI engines.
  • A 90-day roadmap with impact, effort and owner against every item.
Engagements

Three ways to run this

SEO & AI visibility audit · Tier 2

You are in several markets and have no clear diagnosis
one-off · 3 to 5 weeks
  • Hreflang, canonical and geotargeting audit
  • E-E-A-T and medical-review signals
  • Content parity matrix across languages
  • AI-visibility module, 100 prompts per market
  • Prioritised 90-day roadmap
What is inside →

Advisory retainer

You have a team and need it steered
4 h/month · 3-month minimum, then rolling
  • Monthly strategy call plus async questions
  • Review of briefs, specs and migrations before they ship
  • Quarterly priority reset against your data
  • Also available at 8 h/month
  • Fractional SEO lead, 16 h/month
Full ladder →

Prices are not published: each engagement is quoted for its scope and agreed before anything starts. The terms are on the services page.

FAQ

Healthcare SEO questions

Three things. Google applies a higher bar to health content (YMYL), so authorship and medical review are part of the ranking picture. What you may say about a treatment is set by law market by market, so the pages that can rank differ by country. And the results are dominated by institutions: in my check of eight treatment queries, institutions held 72% of the US top-10 organic slots, 62% in Germany and 53% in Spain.
No. I plan around what your regulatory and legal teams approve. Where an SEO choice depends on the regulatory status of a product in a market, such as whether a product page or a disease-information page carries search, I flag it for them to decide.
Yes, with one exclusion. I hold a full-time role at ALK-Abelló, so I do not take clients active in allergy immunotherapy, competitors of ALK-Abelló, or agencies and vendors serving ALK-Abelló. It is written into my terms.
A single clinic is a smaller job: the Tier 1 audit covers one market and up to 500 URLs. This page is about brands and organisations working across several countries.
Per-market segmentation in Search Console and analytics, plus a set of patient and professional questions run against six AI engines. Search Console’s generative AI reports show impressions, not clicks, so they are only part of the picture.

Health brand in more than one country?

Send me your domain and your markets. Thirty minutes, free, and you will know where the problem actually is.

Book a call →